SCHEMBL4428815

SCHEMBL4428815

Cc1ccc2c(c1N1CCNCC1)C=Nc1cc(C(F)(F)F)ccc1N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 3/20 0.41
SOS1 Q07889 3/20 0.40
HTR2C P28335 3/20 0.40
HTR3A P46098 3/20 0.40
HTR1D P28221 2/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
ADRB2 P07550 2/20 0.39
NCF1 P14598 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
HRH4 Q9H3N8 1/20 0.36
NOTUM Q6P988 1/20 0.36
IDH2 P48735 1/20 0.35
HTR1A P08908 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6030680 0.81 HTR3A (0.46) ADRB1HTR2CHTR3AHTR1DHTR3E
SCHEMBL5560257 0.77 ADRB2 (0.43) ADRB1SOS1HTR2CHTR3AHTR1D
SCHEMBL4422947 0.72 ADRB2 (0.42) ADRB1SOS1HTR2CHTR3AHTR1D
SCHEMBL5936578 0.70 CYP1A2 (0.38) ADRB1SOS1HTR2CADRB2NCF1
SCHEMBL3409058 0.70 CHRM1 (0.53) HTR2CHTR3AHTR3EHTR3BHTR3D
SCHEMBL19385666 0.70 ADRB2 (0.55) ADRB1SOS1HTR2CHTR3AHTR1D
SCHEMBL5936593 0.69 HTR1A (0.46) ADRB1HTR2CHTR3AADRB2HTR1A
Hydrochloric Acid SCHEMBL19385658 0.69 MAPT (0.55) ADRB1SOS1HTR2CHTR3AHTR1D
SCHEMBL13179908 0.68 HTR3A (0.58) ADRB1SOS1HTR2CHTR3AHTR1D
SCHEMBL3414137 0.67 CHRM1 (0.71) HTR2CHTR3AHTR3EHTR3BHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622461-B2 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders ACADIA PHARMACEUTICALS INC. (US) 2009-11-24 US disclosed